학술논문
Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes
Document Type
Article
Source
In: Hematology, Transfusion and Cell Therapy . (Hematology, Transfusion and Cell Therapy, 1 January 2023, 45(1):98-101)
Subject
Language
English
ISSN
25311387
25311379
25311379